Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 4
Submit an article Journal homepage
286
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Treatment of the patient with diffuse large B-cell lymphoma with medical co-morbidities: Newer therapies needed

Luis Fayad Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX
&
Fredrick Hagemeister Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TXCorrespondence[email protected]
Pages 657-658 | Published online: 01 Jul 2009

References

  • Pfreundschuh M, Trümper L, Österborg A, Pettergell R, Trneny M, Imric K, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MINT) Group. Lancet Oncol 2006; 7: 379–391
  • Coiffier B, Lepage E, Briere J, Herbretch R, Tilly H, Bouabdallah, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 235–242
  • Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe de'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005; 23: 4117–4126
  • Habermann T M, Weller E A, Morrison V A, Gascoyne R U, Cassileth P A, Cohn J B, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 3121–3127
  • Hasselblom S, Ridell B, Nilsson-Ehle H, Andersson P O. The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma (DLBCL)—a population based study. Leuk Lymphoma 2007; 48: 736–745
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's Lymphoma. The International non-Hodgkin's Lymphoma Project. N Engl J Med 1993; 329(14)987–994
  • Janssen-Heijnen M L, vanSpronsen D J, Lemmens V E, Houterman S, Verheij K D, Coebergh J W. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma. Prognostic impact independent of International Prognostic Index. Br J Haematol 2005; 129: 597–606
  • Krol A D, Le Cessic S, Snuder S, Kluin-Nelemans J C, Kluin P M, Noordijk E M. Non-Hodgkin's lymphoma in the Netherlands. Results from a population based registry. Leuk Lymphoma 2003; 44: 451–458
  • Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for Cancer Drug Registration. A 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004; 22: 4626–4631

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.